Sign Up
HB 216 Hawaii House · 2019 Regular Session

RELATING TO HEALTH CARE INSURANCE.

Summary
Prohibits a health care insurer from requiring an insured diagnosed with stage two cancer to undergo step therapy prior to covering the insured for the drug prescribed by the insured's health care provider, under certain conditions. Requires analysis and report by State Auditor to determine if federal ACA provisions or state sunrise analysis requirements have been triggered. (HB216 HD1)
Bill status in committee 3 of 5 stages cleared
Introduction
Jan 2019
Committee Review
Feb 2019
House Passage
Feb 2019
Senate Passage
Governor
Introduced Jan 17, 2019 Last action Feb 7, 2019
Floor votes · House Feb 4, 2019

How they voted

47–0
Passed · 4 other
Total votes 51
Feb 4, 2019
D Democratic45
42 Yea 3
93% Yea
R Republican5
4 Yea 1
80% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
10
Key actions
3
Committee
4
Feb 7, 2019
Lower · Passed
The committee(s) on CPC recommend(s) that the measure be deferred.
lower
Feb 4, 2019
Committee
Reported from HLT (Stand. Com. Rep. No. 29) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
lower
Feb 4, 2019
House · Passed
House Vote: pass (47-0-4)
house
Jan 29, 2019
Lower · Passed
The committees on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Mizuno, B. Kobayashi, Belatti, Nakamura, Tokioka, Ward; Ayes with reservations: Representative(s) San Buenaventura, Say; Noes: none; and Excused: none.
lower
Jan 22, 2019
Committee
Referred to HLT, CPC, FIN, referral sheet 2
lower
Jan 18, 2019
Introduced
Introduced and Pass First Reading.
lower
Jan 17, 2019
Introduced
Pending introduction.
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.